Home/All Molecules/Pitavastatin

Pitavastatin Range

Comprehensive Pitavastatin portfolio for Franchise & Manufacturing.

Category
pitavastatin
Total Formulations
5
Available Forms
Tablets

Expand Your Business with Our Multiple Divisions


Browse Pitavastatin portfolio by Dosage Form


The Cafoli Advantage for PCD Franchise & Manufacturing

WHO-GMP Quality

Every Pitavastatin batch undergoes rigorous in-house and third-party testing, strictly adhering to WHO-GMP standards for efficacy and safety.

Quality Policy

Monopoly & Branding

Secure exclusive PCD franchise rights for your territory and benefit from our range of premium, marketing-driven product packaging.

Market Strategy

Sales Support

Enhance your sales with Cafoli’s complete kit of marketing materials, including visual aids, MR bags, catch covers, and product cards.

Marketing Tools

Pitavastatin PCD Pharma Franchise Company

Pitavastatin PCD Pharma Franchise Company

Cafoli Lifecare is a trusted Pitavastatin PCD pharma franchise company offering a focused portfolio of 5 Pitavastatin formulations manufactured under WHO-GMP certified facilities. We support distributors and franchise associates across India who want a dependable supply of quality cardiovascular products backed by strong promotional inputs.

What is Pitavastatin?

Pitavastatin is an HMG-CoA reductase inhibitor, a statin that lowers cholesterol by reducing its production in the liver. It effectively lowers LDL cholesterol and triglycerides while modestly raising HDL, helping reduce the risk of cardiovascular events. It has minimal interaction through the CYP3A4 pathway, which can be an advantage in patients on multiple medicines. It is a prescription-only medicine. Learn more via PubChem.

Available Pitavastatin Formulations

Our current Pitavastatin range covers 5 formulations available in the following dosage form: Tablets. Each batch is quality tested to support consistent lipid control for patients managed by our franchise partners.

Therapeutic Applications

Pitavastatin is prescribed for primary hyperlipidaemia and mixed dyslipidaemia, and for cardiovascular risk reduction in high-risk patients including many with diabetes. It is commonly recommended by cardiologists, diabetologists and general physicians managing long-term metabolic and cardiac care.

Why Pitavastatin is a High-Potential Molecule for Distributors

Cardiovascular disease and dyslipidaemia are major and growing health concerns in India, driving sustained demand for statins. Pitavastatin offers a favourable interaction profile that appeals to prescribers treating complex patients, giving franchise partners a differentiated statin for a chronic-use, repeat-prescription market.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers district-wise monopoly rights, WHO-GMP certified manufacturing, DCGI-approved formulations and comprehensive promotional inputs. With more than 1000 franchise partners, we provide reliable supply, transparent pricing and marketing support to help you build a sustainable Pitavastatin business.

References

  1. PubChem - Pitavastatin
  2. PubMed - Pitavastatin Research

Aceclofenac in Modern Clinical Practice

Our formulations of Pitavastatin find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to:


FAQ about Pitavastatin in PCD Franchise

Start Your Pitavastatin Franchise with Cafoli Lifecare

Ready to launch your Pitavastatin PCD franchise? Call us at 9518447302 or email info@cafoli.in to secure district-wise monopoly rights in your territory today.

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions (FAQs)

We currently offer 5 Pitavastatin formulations in tablet form, all manufactured under WHO-GMP certified facilities.

Yes, we grant district-wise monopoly rights so partners can market Pitavastatin exclusively in their allotted territory.

Pitavastatin is prescribed by cardiologists, diabetologists and general physicians managing cholesterol and cardiovascular risk.

Pitavastatin is a statin used to lower LDL cholesterol and triglycerides and reduce cardiovascular risk in dyslipidaemia. It is a prescription-only medicine.

A valid Drug License and GST registration are required to partner with Cafoli Lifecare for a Pitavastatin franchise.